Combining the potent corticosteroid dexamethasone with a typical surface marker of M2 macrophages (CD163) has demonstrated enhanced reduction of necroinflammation and fibrosis in a rat model of fructose-induced NASH (Figure 2). Here, CD163 is linked to metabolic dysfunction-associated steatohepatitis.